Description

FDA-Approved PSGAG for Equine Joint Health and Degenerative Joint Disease

Adequan® i.m. (polysulfated glycosaminoglycan) is the only FDA-approved intramuscular joint therapy that treats the underlying cause of equine degenerative joint disease (DJD) rather than just its symptoms. Trusted by veterinarians for over 30 years, Adequan® i.m. helps support long-term joint health in horses of all breeds, ages, and performance levels.

This veterinary-prescribed injectable is used to treat non-infectious degenerative or traumatic joint conditions—especially in the hock and carpal joints. Adequan® i.m. works by reducing inflammation, restoring synovial joint lubrication, repairing cartilage, and helping to reverse joint damage.

Key Benefits

• FDA-approved treatment for degenerative joint disease in horses

• Reduces inflammation and relieves joint-related lameness

• Promotes cartilage repair and helps restore joint lubrication

• Delivers proven results for long-term joint function and mobility

• No generic equivalent available

Use

For intramuscular injection only. Administer as directed by your veterinarian.

Indication

Recommended for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

Warning

Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.

Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see the Full Prescribing Information.

Description

Adequan is the only joint treatment proven to reduce the inflammation and pain of degenerative joint disease, but also to help stop the degenerative process while stimulating the production of new joint fluid and new cartilage components.

• 100mg/ml.  5ml vial or 50ml vial 
• For Intramuscular Use In Horses Only. Not for Intra-Articular Use.
• Each 5 milliliters of Adequan® i.m. contains 500 mg of Polysulfated Glycosaminoglycan and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH.
• Sodium Chloride may be added to adjust tonicity.
• Polysulfated glycosaminoglycan is a naturally-occurring complex molecule that is the essential building block of the cartilage matrix.
• Adequan travels into injured joints and stimulates production of new cartilage while relieving the symptoms of non-infectious degenerative joint disease.

Adequan^® i.m. (polysulfated glycosaminoglycan). 

Why Adequan i.m. for horses?

• It's the ideal, complete treatment for non-infectious degenerative joint disease. For full prescribing information consult your veterinarian and product insert.
• Used for the treatment of
  
  • non-infectious degenerative joint dysfunction in horses
  • traumatic joint dysfunction in horses
  • associated lameness of the carpal and hock joints in horses
• Intramuscular

Dosage and Administration

• The recommended dose of Adequan i.m. in horses is 500 mg every 4 days for 28 days intramuscularly.
• The injection site must be thoroughly cleansed prior to injection.
• Do not mix Adequan i.m. with other drugs or solvents.